Central nervous system metastatic epithelial ovarian cancer. Clinical parameters and prognostic factors: a multicenter study of Anatolian Society of Medical Oncology

Basit Öğe Kaydı
dc.contributor.authorSeber, S.
dc.contributor.authorTurkmen, E.
dc.contributor.authorHarputoglu, H.
dc.contributor.authorYesil, H.
dc.contributor.authorArpaci, E.
dc.contributor.authorMenekse, S.
dc.contributor.authorPilanci, K.
dc.date.accessioned2024-04-24T17:15:12Z
dc.date.available2024-04-24T17:15:12Z
dc.date.issued2017
dc.departmentDicle Üniversitesien_US
dc.description.abstractCentral nervous system (CNS) metastasis is a rare event in the course of late stage epithelial ovarian cancer (EOC); however its incidence is increasing in parallel with prolonged survival of patients. Objective: The authors assessed the clinical parameters and potential prognostic features in patients with CNS metastatic disease. Materials and Methods: Clinical data of the 33 patients from the participating centers were retrospectively collected and analyzed. Median age at the time of CNS metastasis was 57 years. Median time from the diagnosis of primiuy EOC until CNS metastatic disease was 22 months. Nearly half (45.5%) of the patients had single CNS metastatic lesions and all patients in the study group except two received radiotherapy as palliative treatment. Median overall survival (OS) from the time of CNS metastasis was 15 months (0-66). At univariate analysis only number of brain metastatic lesions (p = 0.001) and presence of extracranial disease (p = 0.004) were strongly associated with OS whereas multimodal treatment, size of metastatic lesions, platinum sensitivity, age, grade, and disease stage at presentation were not. Development of CNS metastasis carries a poor prognosis, however patients with single metastatic lesions and only intracranial metastatic disease can have prolonged survival after appropriate palliative management of their disease.en_US
dc.identifier.doi10.12892/ejgo3465.2017
dc.identifier.endpage231en_US
dc.identifier.issn0392-2936
dc.identifier.issue2en_US
dc.identifier.pmid29953785
dc.identifier.scopus2-s2.0-85017164346
dc.identifier.scopusqualityN/A
dc.identifier.startpage227en_US
dc.identifier.urihttps://doi.org/10.12892/ejgo3465.2017
dc.identifier.urihttps://hdl.handle.net/11468/18373
dc.identifier.volume38en_US
dc.identifier.wosWOS:000396649000012
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisher7847050 Canada Incen_US
dc.relation.ispartofEuropean Journal of Gynaecological Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCentral Nervous System Epithelial Ovarian Canceren_US
dc.subjectMetastasisen_US
dc.subjectPalliative Managementen_US
dc.titleCentral nervous system metastatic epithelial ovarian cancer. Clinical parameters and prognostic factors: a multicenter study of Anatolian Society of Medical Oncologyen_US
dc.titleCentral nervous system metastatic epithelial ovarian cancer. Clinical parameters and prognostic factors: a multicenter study of Anatolian Society of Medical Oncology
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu